Cite
HARVARD Citation
Isakoff, S. et al. (n.d.). A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors. European journal of cancer. pp. S137-S138. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Isakoff, S. et al. (n.d.). A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors. European journal of cancer. pp. S137-S138. [Online].